Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells

Cellular Immunology

Volumn 223, Issue 2, 2003, Pages 120-132

  Vassiliou, Evros ^a   Jing, Huie ^a   Ganea, Doina ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Dendritic cells; EP2 EP4 receptors; Inflammation; PGE2; TNF

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CELL PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOPROTEIN P 15095; INTERLEUKIN 10; LIGAND; MESSENGER RNA; PEPTIDOGLYCAN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BONE MARROW; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; MALE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEAL EXUDATE CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION;

MURINAE;

EID: 0141727577     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(03)00158-8     Document Type: Article

References (68)

1. Banchereau J., Steinman R.M. The dendritic cell and the control of immunity. Nature. 392:1998;245-252.
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:2000;767-811.
3. Cella M., Lanzavecchia A., Scheidegger D., Palmer-Lehmann K., Lane P., Albert G. Ligation of CD40 on dendritic cells triggers the production of high levels of IL-12 and enhance T cell stimulatory capacity. J. Exp. Med. 184:1996;747-752.
4. Verhasselt V., Buelens C., Willem F., De Groot D., Goldman M. Bacterial lipopolysachharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells. J. Immunol. 158:1997;2919-2925.
5. Sallusto F., Palermo B., Lenig D., Miettinen M., Matikainen S., Julkunen I., Forster R., Burgtahler R., Lipp M., Lanzavacchia A. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29:1999;1617-1625.
6. Cella M., Engering A., Pinet V., Pieters J., Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 388:1997;782-787.
7. Rescigno M., Citterio S., Thery C., Rittig M., Medaglini D., Pozzi G., Amigorena S., Ricciardi-Castagnoli P. Bacteria induce neo-biosynthesis, stabilization, and surface expression of functional class I molecules on mouse dendritic cells. Proc. Natl. Acad. Sci. USA. 95:1998;5229-5234.
8. Sallusto F., Scherli P., Loetscher P., Schaniel C., Lenig D., Mackay C.R., Qin S., Lanzavecchia A. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28:1998;2760-2769.
9. Sozzani S., Altavena P., D'Amico G., Luini W., Bianchi G., Kataura M., Imai T., Yoshie O., Bonecchi R., Mantovani A. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161:1998;1083-1086.
10. Steinman R.M., Pack M., Inaba K. Dendritic cells in the T cell areas of lymphoid organs. Immunol. Rev. 165:1997;25-37.
11. Randolph G.J. Dendritic cell migration to lymph nodes: cytokines, chemokines and lipid mediators. Semin. Immunol. 13:2001;267-274.
12. Ingulli E., Ulman D.R., Lucido M.M., Jenkins M.K. In situ analysis reveals physical interactions between CD11b+ dendritic cells and antigen-specific CD4 T cells after subcutaneous injection of antigen. J. Immunol. 169:2002;2247-2252.
13. Underhill D., Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 14:2002;103-110.
14. Huang Q., Liu D., Majewski P., Schulte L.C., Korn J.M., Young R.A., Lander E.S., Hacohen N. The plasticity of dendritic cell responses to pathogens and their components. Science. 294:2001;870-875.
15. O'Neill A.J. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immunol. 23:2002;296-300.
16. Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J. Invest. Med. 43:1995;227-235.
17. Cross A., Asher L., Seguin M., Yuan L., Kelly N., Hammack C., Sadoff J., Gemski P. Jr. The importance of a lipopolysachharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli. J. Clin. Invest. 96:1995;676-686.
18. Benini J., Ehlers E.M., Ehlers S. Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent mycobacterium avium. J. Pathol. 189:1999;127-137.
19. Mannel D.N., Echtenacher B. TNF in the inflammatory response. Chem. Immunol. 74:2000;141-161.
20. Hanada T., Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13:2002;413-421.
21. Criscione L.G., St. Clair E.W. Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases. Curr. Opin. Rheumatol. 14:2002;204-211.
22. Abuzakouk M., Feighery C., Jackson J. Tumour necrosis factor blocking agents: a new therapeutic modality for inflammatory disorders. Br. J. Biomed. Sci. 59:2002;173-179.
23. Flavell R.A. The relationship of inflammation and initiation of autoimmune disease: role of TNF super family members. Curr. Top. Microbiol. Immunol. 266:2002;1-9.
24. Shanahan J.C., St. Clair W. Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease. Clin. Immunol. 103:2002;231-242.
25. Debets J.M., Ruers T.J., van der Linden M.P., van der Linden C.J., Buurman W.A. Inhibitory effect of corticosteroids on the secretion of tumour necrosis factor (TNF) by monocytes is dependent on the stimulus inducing TNF synthesis. Clin. Exp. Immunol. 78:1989;224-229.
26. Gerard C., Bruyns C., Marchand A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:1993;547-550.
27. Siegmund B., Eigler A., Moeller J., Greten T.F., Hartmann G., Endres S. Suppression of tumor necrosis factor-α production by interleukin-10 is enhanced by cAMP-elevating agents. Eur. J. Pharmacol. 321:1997;231-239.
28. Chao T.C., Chao H.H., Chen M.F., Lin J.D. Somatostatin modulates the function of kupffer cells. Regul. Pept. 69:1997;143-149.
29. Delgado M., Munoz-Elias E.J., Kan Y., Gozes I., Fridkin M., Brenneman D.E., Gomariz R.P., Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit TNFα transcriptional activation by regulating NF-kB and CREB/c-Jun. J. Biol. Chem. 273:1998;31427-31436.
30. Delgado M., Pozo D., Martinez C., Leceta J., Calvo J.R., Ganea D., Gomariz R.P. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies. J. Immunol. 162:1999;2358-2367.
31. Taherzadeh S., Sharma S., Chhajlani V., Gantz I., Rajora N., Demitri M.T., Kelly L., Zhao H., Ichiyama T., Catania A., Lipton J.M. Alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. Am. J. Physiol. 276:1999;R1289-R1294.
32. Di Battista J.A., Martel-Pelletier J., Pelletier J. Suppression of tumor necrosis factor (TNF-alpha) gene expression by prostaglandin E(2). Role of early growth response protein-1 (Egr-1). Osteoarthritis Cartilage. 7:1999;395-398.
33. Farmer P., Pugin J. Beta-adrenergic agonists exert their anti-inflammatory effects in monocytic cells through the IkappaB/NF-kappaB pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:2000;L675-L682.
34. Ignatowski T.A., Kunkel S.L., Spengler R.N. Interactions between the alpha(2)-adrenergic and the prostaglandin response in the regulation of macrophage-derived tumor necrosis factor. Clin. Immunol. 96:2000;44-51.
35. Kim J.G., Hahn Y.S. IFN-gamma inhibits the suppressive effects of PGE2 on the production of tumor necrosis factor-alpha by mouse macrophages. Immunol. Invest. 29:2000;257-269.
36. Straub R.H., Gunzler C., Miller L.E., Cutolo M., Scholmerich J., Schill S. Anti-inflammatory cooperativity of corticosteroids and norepinephrine in rheumatoid arthritis synovial tissue in vivo and in vitro. FASEB J. 16:2002;993-1000.
37. Dooper M.M., Wassink L., M'Rabet L., Graus Y.M. The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype. Immunology. 107:2002;152-159.
38. Denys A., Udalova I.A., Smith C., Williams L.M., Ciesielski C.J., Campbell J., Andrews C., Kwaitkowski D., Foxwell B.M.J. Evidence for a dual mechanism for IL-10 suppression of TNF-α production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-κB in primary human macrophages. J. Immunol. 168:2002;4837-4845.
39. Woods J.M., Amin M.A., Katschke K.J. Jr., Volin M.V., Ruth J.H., Connors M.A., Woodruff D.C., Kurata H., Arai K., Haines 3rd G.K., Kumar P., Koch A.E. Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis. Hum. Gene Ther. 13:2002;381-393.
40. Pilette C., Ouadrhiri Y., Van Snick J., Renauld J.C., Staquet P., Vaerman J.P., Sibille Y. IL-9 inhibits oxidative burst and TNF-alpha release in lipopolysachharide-stimulated human monocytes through TGF-beta. J. Immunol. 168:2002;4103-4111.
41. Needleman P., Turk J., Jakschik B., Morrison A., Lefkowitz J. Arachidonic acid metabolism. Annu. Rev. Biochem. 55:1986;69-102.
42. Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23:2002;144-150.
43. Kudela P., Schwarczova Z., Sedlak J., Bizik J. Conditioned medium from HeLa cells enhance motility of human monocyte-derived dendritic cells but abrogates their maturation and endocytic activity. Neoplasma. 48:2001;382-388.
44. Zelle-Rieser C., Ramoner R., Artner-Dworzak E., Casari A., Bartsch G., Thurnher M. Human monocyte-derived dendritic cells are deficient in prostaglandin E2 production. FEBS Lett. 511:2002;123-126.
45. Betz M., Fox B. Prostaglandin E2 inhibits production of Th1 lymphokines, but not of Th2 lymphokines. J. Immunol. 146:1991;108-113.
46. Katamura K., Shintaku N., Yamauchi Y., Fukui T., Ohshima Y., Mayumi M., Furusho K. Prostaglandin E2 at priming of naïve CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. J. Immunol. 155:1995;4604-4612.
47. Kalinski P., Hilkens C.M., Snijders A., Snijderwint F.G., Kapsenberg M.L. Dendritic cells obtained from peripheral blood precursors in the presence of PGE2 promote Th2 responses. Adv. Exp. Med. Biol. 417:1997;363-367.
48. Harizi H., Juzan M., Grosset C., Rashedi M., Gualde N. Dendritic cells issued in vitro from bone marrow produce PGE2 that contributes to the immunomodulation induced by antigen-presenting cells. Cell. Immunol. 209:2001;19-28.
49. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 123:1999;77-92.
50. Procopio D.O., Teixeira M.M., Camargo M.M., Travassos L.R., Ferguson M.A., Almeida I.C., Gazzinelli R.T. Differential inhibitory mechanism of cyclic AMP on TNF-alpha and IL-12 synthesis by macrophages exposed to microbial stimuli. Br. J. Pharmacol. 127:1999;1195-1205.
51. Pulendran B., Banchereau J., Maraskovsky E., Maliszewski C. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol. 22:2001;41-47.
52. Ardavin C., Martinez del Hoyo G., Martin P., Anjuere F., Arias C.F., Martin A.R., Ruiz S., Parrillas V., Hernandez H. Origin and differentiation of dendritic cells. Trends Immunol. 22:2001;691-700.
53. Morelli A.E., Zahorchak A.F., Larregina A.T., Colvin B.L., Logar A.J., Takayama T., Falo L.D., Thompson A.W. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood. 98:2001;1512-1523.
54. Yrlid U., Wick M.J. Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter. J. Immunol. 169:2002;108-116.
55. Han J., Brown T., Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171:1990;465-475.
56. ′ poly(A) metabolism in tumor necrosis factor-α regulation J. Biol. Chem. 272:1997;21120-21127.
57. Zhu W., Downey J.S., Gu J., Di Padovva F., Gram H., Han J. Regulation of TNF expression by multiple mitogen-activated protein kinase pathways. J. Immunol. 164:2000;6349-6358.
58. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79:1999;1193-1226.
59. Meja K.K., Bames P.J., Giembycz M.A. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysachharide-induced tumor necrosis factor-alpha generation. Br. J. Pharmacol. 122:1997;149-157.
60. Ikegami R., Sugimoto Y., Segi E., Katsuyama M., Karahashi H., Amano F., Maruyama T., Yamane H., Tsuchiya S., Ichikawa A. The expression of prostaglandin receptors EP2 and EP4 and their different regulation by lipopolysachharide in C3H/HeN peritoneal macrophages. J. Immunol. 166:2001;4689-4696.
61. Shinomiya S., Naraba H., Ueno A., Utsunomiya I., Maruyama T., Ohuchida S., Ushikubi F., Yuki K., Narumiya S., Sugimoto Y., Ichikawa A., Oh-ishi S. Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. Biochem. Pharmacol. 61:2001;1153-1660.
62. Katsuyama M., Ikegami R., Karahashi H., Amano F., Sugimoto Y., Ichikawa A. Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1. Biochem. Biophys. Res. Commun. 251:1998;727-731.
63. Scandella E., Men Y., Gillessen S., Forster R., Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood. 100:2002;1354-1361.
64. Fennekohl A., Sugimoto Y., Segi E., Maruyama T., Ichikawa A., Puschel G.P. Contribution of the two Gs-coupled PGE2-receptors EP2-receptor and EP4-receptor to the inhibition by PGE2 of the LPS-induced TNFalpha-formation in Kupffer cells from EP2- or EP4-receptor deficient mice. Pivotal role for the EP4-receptor in wild type Kupffer cells. J. Hepatol. 36:2002;328-334.
65. Harizi H., Juzan M., Pitard V., Moreau J.-F., Gualde N. Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10, which downregulates dendritic cell functions. J. Immunol. 168:2002;2255-2263.
66. Seldon P.M., Barnes P.J., Giembycz M.A. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysachharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes. Cell. Biochem. Biophys. 29:1998;179-201.
67. Luft T., Jefford M., Luetjens P., Toy T., Hochrein H., Masterman K.-A., Maliszewski C., Shortman K., Cebon J., Maraskovsky E. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets. Blood. 100:2002;1362-1372.
68. Randolph G.J. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Seminars Immunol. 13:2001;267-274.